Triple therapy with telaprevir/boceprevir + pegylated-interferon+ribavirin can achieve excellent antiviral efficacy, but it can be burdened with resistance development at failure.
Cento, V., Di Paolo, D., Di Carlo, D., Micheli, V., Tontodonati, M., De Leonardis, F., et al. (2015). Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome. DIGESTIVE AND LIVER DISEASE, 47(2), 157-163 [10.1016/j.dld.2014.11.010].
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome
CENTO, VALERIA;SARRECCHIA, CESARE;ANDREONI, MASSIMO;ANGELICO, MARIO;PERNO, CARLO FEDERICO;CECCHERINI SILBERSTEIN, FRANCESCA
2015-02-01
Abstract
Triple therapy with telaprevir/boceprevir + pegylated-interferon+ribavirin can achieve excellent antiviral efficacy, but it can be burdened with resistance development at failure.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2015_Hepatitis-C-virus-RNA-levels-at-week-2-of-telaprevir-boceprevir-administration-are-predictive-of-virological-outcome_2014_Digestive-and-Liver-Disease.pdf
accesso aperto
Licenza:
Copyright dell'editore
Dimensione
252.68 kB
Formato
Adobe PDF
|
252.68 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
